DVA Share Price

Open 61.23 Change Price %
High 61.69 1 Day -3.77 -6.15
Low 56.14 1 Week -3.22 -5.30
Close 57.49 1 Month 0.26 0.45
Volume 7743544 1 Year -9.01 -13.55
52 Week High 70.16
52 Week Low 54.50
DVA Important Levels
Resistance 2 62.63
Resistance 1 60.51
Pivot 58.44
Support 1 54.47
Support 2 52.35
NYSE USA Most Active Stocks
RAI 65.40 -2.23%
RAI 65.40 -2.23%
EMC 29.05 0.97%
EMC 29.05 0.97%
EMC 29.05 0.97%
SE 40.68 -0.78%
PCS 11.84 -0.92%
PCS 11.84 -0.92%
PCS 11.84 -0.92%
BAC 25.02 -0.56%
More..
NYSE USA Top Gainers Stocks
POM 26.93 26.79%
POM 26.93 26.79%
GLF 0.34 25.93%
GLF 0.34 25.93%
QUAD 22.58 14.21%
ANW 4.65 13.41%
MSB 23.45 12.20%
MSB 23.45 12.20%
FNP 35.24 12.02%
FNP 35.24 12.02%
More..
NYSE USA Top Losers Stocks
ENL 15.81 -66.25%
ENL 15.81 -66.25%
ENL 15.81 -66.25%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
STP 0.53 -39.77%
STP 0.53 -39.77%
STP 0.53 -39.77%
STP 0.53 -39.77%
More..

DaVita healthCare Partners Inc. (NYSE: DVA)

DVA Technical Analysis 5
As on 22nd Sep 2017 DVA Share Price closed @ 57.49 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 63.85 & Strong Sell for SHORT-TERM with Stoploss of 60.15 we also expect STOCK to react on Following IMPORTANT LEVELS.
DVA Target for September
1st Target up-side 63.87
2nd Target up-side 67.6
3rd Target up-side 71.32
1st Target down-side 53.25
2nd Target down-side 49.52
3rd Target down-side 45.8
DVA Other Details
Segment EQ
Market Capital 10969092096.00
Sector Healthcare
Industry Specialized Health Services
Offical website http://www.davita.com
DVA Address
DVA
2000 16th Street
Denver, CO 80202
United States
Phone: 303-405-2100
DVA Latest News
Interactive Technical Analysis Chart DaVita healthCare Partners Inc. ( DVA NYSE USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on DaVita healthCare Partners Inc.
DVA Business Profile
DaVita HealthCare Partners Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease. It operates kidney dialysis centers and provides related lab services primarily in outpatient dialysis centers and in contracted hospitals. The company offers outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers DaVita Rx, a pharmacy that provides oral medications to patients with ESRD; disease management services; vascular access services; ESRD clinical research programs; physician services; and direct primary care services. As of March 31, 2014, it operated 2,173 outpatient dialysis centers, including 2,098 centers located in the United States; and 75 centers located in 10 countries outside the United States. The company was formerly known as DaVita Inc. and changed its name to DaVita HealthCare Partners Inc. in November 2012. DaVita HealthCare Partners Inc. was founded in 1994 and is headquartered in Denver, Colorado.